ERT

ERT launches eCOA platform

Monday, September 25, 2017

ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, announced a technology platform that provides fast, regulatory compliant and cost-effective clinical outcome assessment (COA) data capture during vaccine clinical development. The platform reduces the time needed to develop electronic diary cards by 75%, enabling vaccine researchers to benefit from the significant advantages electronic COA (eCOA) delivers without jeopardizing clinical development timelines.

[Read More]

ERT named finalist for 2017 Scrip Award

Friday, September 22, 2017

ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, announced that ERT Trial Oversight—its centralized, cloud-based clinical trial management solution—has been named a finalist for the 2017 Scrip Best Sponsor-Focused Technological Development in Clinical Trials Award.

[Read More]

ERT acquires Biomedical Systems

Tuesday, September 12, 2017

ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, has acquired Biomedical Systems, a well-recognized provider of reliable imaging, as well as cardiac safety and respiratory data collection solutions. Financial terms of the transaction were not disclosed.

[Read More]

ERT launches Express Overread for respiratory clinical trials

Monday, September 11, 2017

ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, announced the availability of its Express Overread service for clinical trials that require spirometry and pulmonary function testing (PFT). The service provides centralized overread of PFT results in one hour or less, enabling investigative sites to quickly and reliably determine which patients are eligible to be included and randomized in clinical trials.

[Read More]

WCG’s MedAvante-ProPhase expands executives

Tuesday, August 15, 2017

WIRB-Copernicus Group (WCG), a provider of solutions that measurably improve the quality and efficiency of clinical research, announced that industry experts Steven Herne and Michael Cioffi have joined the leadership of MedAvanteProPhase, the Group’s electronic clinical outcomes assessment (eCOA) arm. Herne and Cioffi are tasked with expanding MedAvante-ProPhase’s already formidable portfolio of services and technologies, which improve the quality of clinical trial data collection and analysis in the fields of CNS and mental health.

[Read More]

ERT and Orbita collaborate to improve patient retention and trial efficiency

Monday, June 5, 2017

Mobile health applications have transformed the way many people approach their health. Applications can now track food and nutrition intake, activity levels and even sleep habits. Similar health applications have also permeated clinical research; in fact, there has been an increased demand for and utilization of mobile health applications for data capture during clinical trials. This form of data capture is aimed at streamlining the data procurement process, ultimately improving the time in which results from a trial can be analyzed and interpreted.

[Read More]

Orbita, ERT collaborate to optimize data capture

Tuesday, May 23, 2017

Orbita, a provider of voice-first software for connected home healthcare, announced a collaboration with ERT to research innovative new approaches to data procurement and management for pharmaceutical and device customers seeking to streamline clinical trials. The collaboration combines the advanced capabilities of ERT’s EXPERT technology platform for clinical trial data collection, processing, and analysis with Orbita Voice, a first-of-its-kind solution for creating conversational applications using intelligent voice agents such as Amazon Alexa and Google Assistant.

[Read More]

ERT launches Solution for Lung Clearance Index (LCI)

Monday, May 22, 2017

ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, introduced an advanced respiratory clinical trial solution to centrally capture, measure and analyze Lung Clearance Index data, in near real-time, to assess lung performance with more precision than traditional spirometry measures.

[Read More]

ERT acquires imaging solution from Cleveland Clinic

Tuesday, May 9, 2017

ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, acquired ImageIQ, originally established as Cleveland Clinic’s Biomedical Imaging and Analysis Center. The acquisition enables ERT to offer advanced, end-to-end clinical trial imaging analysis using best-in-class technology that delivers compliant data for use in clinical development.

[Read More]